Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Lonza Expands Singapore Bioservices | Contract Pharma

What are you searching for?

Sign in
Breaking News

Lonza Expands Singapore Bioservices

Lonza is investing nearly $12 million to expand its biopharmaceutical development services in Singapore.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Lonza is investing nearly $12 million to expand its biopharmaceutical development services in Singapore. Lonza’s Development Services business provides customized services for the development of robust biomanufacturing processes.

The expansion will add 1,858 m² of lab space and associated equipment, and will support cell line construction, upstream and downstream process development, and a broad range of analytical services. Lonza currently offers these services in its Slough, UK facility with a limited offering in Singapore. The facility is expected to come on-line in by mid-2012.

“This further investment in our Singapore location is driven by the increased demand we are seeing on a global basis,” said Janet White, head of development services at Lonza. “We are looking forward to offering the full range of our GS Gene Expression System and other technologies in Asia. The location is advantageous to many of our customers from across the globe, and in particular, with our growing set of customers based in the region.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics